Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
E2F8 | hg38_v1_chr11_-_19241598_19241628 | 0.30 | 9.1e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.1 | 2.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.9 | 2.8 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 | 2.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 1.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 1.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 1.8 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 1.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 1.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 1.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 3.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 3.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 3.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 1.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.0 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 6.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |